The decrease in asthma-related mortality in France;Diminution de la mortalité par asthme en France

Revue des Maladies Respiratoires

Volumn 25, Issue 7, 2008, Pages 814-820

  Tual, S ^a,b   Godard, P ^c   Bousquet, J ^a,c   Annesi Maesano, I ^a,b  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Asthma; France; Mortality; Regional disparities; Trend

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ARTICLE; ASTHMA; CONSENSUS; CONTROLLED STUDY; FEMALE; FRANCE; HEALTH EDUCATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CARE; SEX DIFFERENCE;

EID: 55049106657     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0761-8425(08)74346-8     Document Type: Article

References (26)

1. Masoli M, Fabian D, Holt S, Beasley R: The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59: 469-78.
2. Com-Ruelle L, Dumesnil S, Lemaître D: L'asthme en France selon les stades de gravité. Centre de recherche, d́tudes et de documentation en économie de la santé (CREDES), Impressions Offset, Vanves, 2000, 182 pages.
3. Neukirch F, Pin I, Knani J, Henry C, Pison C, Liard R, Romazzini S, Bousquet J: Prevalence of asthma and asthma-like symptoms in three French cities. Respir Med 1995; 89: 685-92.
4. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351: 1225-32.
5. Ministère de l'Emploi et de la Solidarité. Programmes d'actions, de prévention et de prise en charge de l'asthme 2002-2005. 2002. Disponible sur http://www.sante.gouv.fr/htm/pointsur/asthme/index.htm.
6. Delmas MC, Zeghnoun A, Jougla E: Mortalité par asthme en France métropolitaine, 1980-1999. BEH 2004; 47: 221-3.
7. Getahun D, Demissie K, Rhoads GG: Recent trends in asthma hospitalization and mortality in the United States. J Asthma 2005; 42: 373-8.
8. Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC: Surveillance for asthma - United States, 1980-1999. MMWR Surveill Summ 2002; 51: 1-13.
9. Australian Centre for Asthma Monitoring. Asthma in Australia 2005. Australian Institute of Health and Welfare, Canberra, 2005.
10. Pearce N, Beasley R, Crane J, Burgess C, Jackson R: End of the New Zealand asthma mortality epidemic. Lancet 1995; 345: 41-4.
11. Soler M, Chatenoud L, Negri E, La Vecchia C: Trends in asthma mortality in Italy and Spain, 1980-1996. Eur J Epidemiol 2001; 17: 545-9.
12. Anderson HR, Gupta R, Strachan DP, Limb ES: 50 years of asthma: UK trends from 1955 to 2004. Thorax 2007; 62: 85-90.
13. Campbell MJ, Cogman GR, Holgate ST, Johnston SL: Age specific trends in asthma mortality in England and Wales, 1983-95: results of an observational study. BMJ 1997; 314: 1439-41.
14. Wever-Hess J, Wever AM: Asthma statistics in The Netherlands 1980-94. Respir Med 1997; 91: 417-22.
15. Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, Nieminen MM, Kontula E, Laitinen LA: A 10 year asthma programme in Finland: major change for the better. Thorax 2006; 61: 663-70.
16. National Heart, Lung and Blood Institute, National Institutes of Health. Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report, Global Initiative for Asthma (GINA 1995), Publication no.93-3659. Bethesda: National Institutes of Health, 1995.
17. Suissa S, Ernst P: Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001; 107: 937-44.
18. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O, et al: Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991; 325: 388-92.
19. Cooreman J, Segala C, Henry C, Neukirch F: Trends in asthma-induced mortality in France from 1970-90. Tuber Lung Dis 1994; 75: 182-7.
20. Tual S, Godard P, Piau JP, Bousquet J, Annesi-Maesano I: Asthma-related mortality in France, 1980-2005: decline since the last decade. Allergy 2008; 63: 621-3.
21. Bousquet J, Hatton F, Godard P, Michel FB. Asthma mortality in France. J Allergy Clin Immunol 1987; 80: 389-94.
22. Annesi-Maesano I, Kalaboka S, Piau JP: L'asthme est-il une maladie toujours potentiellement mortelle? Presse Med 2008; 37: 107-15.
23. Pascal L, Delmas MC, Fuhrman C: Hospitalisations pour asthme en France métropolitaine, 1998-2002. Evaluation à partir des données du PMSI. 2007.
24. Lalloo UG, Malolepszy J, Kozma D, Krofta K, Ankerst J, Johansen B, Thomson NC: Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma. Chest 2003; 123: 1480-7.
25. Godard P, Huas D, Sohier B, Pribil C, Boucot I: ER'Asthme, contrôle de l'asthme chez 16580 patients suivis en médecine géné rale. Presse Med 2005; 34: 1351-7.
26. Sears MR, Rea HH, de Boer G, Beaglehole R, Gillies AJ, Holst PE, O'Donnell TV, Rothwell RP: Accuracy of certification of deaths due to asthma. A national study. Am J Epidemiol 1986; 124: 1004-11.